Prot #BTCRC-HN17-111: Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-Positive Salivary Gland Carcinoma

Project: Research project

StatusActive
Effective start/end date10/9/1910/9/22

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC-HN17-111)
  • Merck Sharp & Dohme Corp. (Prot #BTCRC-HN17-111)